READDI (@READDI_Inc) header
READDI (@READDI_Inc) profile picture

Global nonprofit that develops broad-spectrum antivirals to make treatment available to everyone, everywhere when the next pandemic arises.

Chapel Hill, NC
Joined August 2023
Photo by READDI (@READDI_Inc)Photo by READDI (@READDI_Inc)Photo by READDI (@READDI_Inc)Photo by READDI (@READDI_Inc)Photo by READDI (@READDI_Inc)Photo by READDI (@READDI_Inc)Photo by READDI (@READDI_Inc)Photo by READDI (@READDI_Inc)Photo by READDI (@READDI_Inc)Photo by READDI (@READDI_Inc)
With @READDI_Inc's broad-spectrum, small molecule antivirals, the world can avoid another catastrophic viral outbreak. A harsh truth: The world economy never recovered from the COVID-19 pandemic /via @globeandmail theglobeandmail.com/business…
34
@READDI_Inc has not forgotten. We are developing antivirals that work broadly against all viruses in virus families of pandemic potential. We’ve forgotten pandemic prep politi.co/3SbmgqH via @politico
1
3
79
Big day for us in Rome today - pushing forwards the #100DaysMission for pandemic preparedness 👇
We are live at the launch of the 3rd implementation report of the #100DaysMission Opening Remarks by Prof Rino Rappuoli, Scientific Director of the Biotecnopolo di Siena Foundation & head of MAD Lab Toscana Life Sciences 🦠 Register for the Zoom link: bitly.ws/39WCB
1
4
929
@READDI_Inc was pleased to contribute to this important report, highlighting progress made in 2023 and work planned in 2024. Learn more: tinyurl.com/yckenrdk
1
13
@READDI_Inc is developing antiviral treatments now to become the standard of care for the next unknown viral threat, also known as Disease X. Learn more about how READDI is contributing to the R&D pipeline for pandemic pathogens. lnkd.in/eQYcNaRc
1
2
73
‘Disease X’ is a placeholder for an unknown pathogen that could cause a global emergency. History has taught us that we must anticipate new threats. Failing to prepare leaves the world prepared to fail. At #WEF24 today, I spoke about @WHO initiatives that are supporting countries to prepare better, including investment in local production, surveillance and development of a generational #PandemicAccord.
748
248
166
549
268,241
Top pharma CEO says preparedness for a new pandemic has not improved cnb.cx/3S9buBA “...ideally we would live in a world where that inter-pandemic preparedness, like we do in defense, like we do in other areas, would continue so we’re ready for the next pandemic.”
8
One of @READDI_Inc's foundational steps was to create a landscape assessment of all antiviral drug development work, both active and abandoned, targeting the virus families of high pandemic risk. A huge thank you to SciVida for executing the database. tinyurl.com/4f33hefa
23
“What about Disease X? What is the value of a portfolio of antiviral drugs for a disease that does not yet exist?” @READDI_Inc CEO Jimmy Rosen discussed solutions at the #MIHealthSummit. Thank you @MilkenInstitute for the opportunity! tinyurl.com/2bmbny4m
106
What if it took 100 days to make a safe and effective vaccine against any virus? 💉 Read more about the 100 Days Mission for vaccines from our partners @CEPIvaccines 👇
CEPI has an ambitious $3.5 billion equitable access-focussed R&D plan that will help the world create safe and effective vaccines in 100 days #100DaysMission 100days.cepi.net
1
4
104
“We're very focused on pandemic solutions—making broad-spectrum small molecule antiviral drugs affordable and accessible to everybody who needs them, when they need them, where they need them.” — CEO Jimmy Rosen #MIHealthSummit @MilkenInstitute
1
3
85
The paramyxovirus family includes some of the fastest-spreading pathogens in human history—think measles—as well as some of the deadliest. Could this group of viruses spark the next pandemic? @KatherineJWu reports: theatlantic.com/science/arch…
1
11
The GAO says “Pandemic antivirals represent what economists call a ‘market failure’—prices do not reflect the benefit these drugs offer to society.” tinyurl.com/3v6aehaa @READDI_Inc is working on a solution: tinyurl.com/2bhjj6kw
13